What is JBT Marel Corporation's earnings per share (EPS)?

JBT Marel Corporation (JBTM) reported diluted earnings per share of -$0.98 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

JBT Marel Corporation (JBTM) Financials

JBTM

Trailing 12 months to June 30, 2026

Revenue $3.9B +45.9% YoY

Net Income $192.5M +239.4% YoY

EPS (Diluted) $3.68 YoY not available

Free Cash Flow $310.1M +10.1% YoY

Market Cap $5.9B as of Sep 11, 2026

Price / Sales 1.5x on $3.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 30.8x on $192.5M net income, trailing 12 months to June 30, 2026

Price / Book 1.3x on $4.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JBTM SEC filings page.

JBT Marel Corporation (JBTM) reported $3.9B in revenue over the twelve months to Jun 30, 2026, up 45.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JBTM FY2025 2026-08-30

JBT Marel's dominant mechanic is acquisition-scaled expansion, with gross profit growing faster than operating earnings while cash conversion remains positive.

From FY2024 to FY2025, revenue more than doubled while goodwill more than quadrupled, indicating that the new scale came primarily through a much larger acquired-asset base rather than organic volume alone. Yet operating cash flow of $341.7M exceeded free cash flow of $238.1M, showing that the accounting loss did not prevent cash generation, although reinvestment absorbed part of that cash.

A 35.1% gross margin still produced only a 5.0% operating margin, so the main pressure sits below gross profit rather than in product-level economics. Depreciation and amortization of $266.2M plus interest expense of $114.4M help explain why net margin reached -1.3%.

The balance sheet is less debt-heavy but tighter in the near term: debt-to-equity was only 0.3x, while the current ratio fell to 1.0x. That combination suggests equity and acquired assets strengthened long-term solvency, but short-term obligations now roughly match current assets.

Financial Health Signals

Financial Health Score 51/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of JBT Marel Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

JBT Marel Corporation has an operating margin of 5.0%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 62/100, indicating healthy but not exceptional operating efficiency. This is down from 6.9% the prior year.

Growth

JBT Marel Corporation's revenue surged 121.3% year-over-year to $3.8B, reflecting rapid business expansion. This strong growth earns a score of 95/100.

Leverage

JBT Marel Corporation has elevated debt relative to equity (D/E of 0.33), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 23/100, reflecting increased financial risk.

Liquidity

JBT Marel Corporation's current ratio of 0.98 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

JBT Marel Corporation has a free cash flow margin of 6.3%, earning a moderate score of 53/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

JBT Marel Corporation posts a -1.1% return on equity (ROE), meaning it loses $1 for every $100 of shareholders' equity. This results in a returns score of 53/100. This is down from 5.5% the prior year.

Altman Z-Score Distress

1.74

JBT Marel Corporation scores 1.74, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($5.9B) relative to total liabilities ($3.7B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

3/9

JBT Marel Corporation passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

JBT Marel Corporation reported a net loss of $50.5M while generating $341.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

1.66x

JBT Marel Corporation earns $1.66 in operating income for every $1 of interest expense ($189.4M vs $114.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$981.0M

YoY+4.9%

QoQ+4.8%

5Y CAGR+15.6%

10Y CAGR+11.6%

JBT Marel Corporation generated $981.0M in revenue in Q2 2026. This represents an increase of 4.9% from the same quarter a year earlier. Against the prior quarter it is up 4.8%.

Net Income

$28.0M

YoY+833.3%

QoQ-37.8%

5Y CAGR-1.7%

10Y CAGR+4.1%

JBT Marel Corporation reported $28.0M in net income in Q2 2026. This represents an increase of 833.3% from the same quarter a year earlier. Against the prior quarter it is down 37.8%.

EPS (Diluted)

$0.54

YoY+671.4%

QoQ-37.2%

5Y CAGR-10.7%

10Y CAGR-1.5%

JBT Marel Corporation earned $0.54 per diluted share (EPS) in Q2 2026. This represents an increase of 671.4% from the same quarter a year earlier. Against the prior quarter it is down 37.2%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$77.0M

YoY-8.3%

QoQ-17.2%

5Y CAGR+18.3%

JBT Marel Corporation generated $77.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 8.3% from the same quarter a year earlier. Against the prior quarter it is down 17.2%.

Cash & Debt

$112.0M

YoY-13.8%

QoQ-51.3%

5Y CAGR-11.2%

10Y CAGR+12.3%

JBT Marel Corporation held $112.0M in cash against $1.7B in long-term debt as of Q2 2026.

Dividends Per Share

$0.10

YoY0.0%

QoQ0.0%

JBT Marel Corporation paid $0.10 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

52M

YoY-0.2%

QoQ-0.4%

5Y CAGR+10.3%

10Y CAGR+5.9%

JBT Marel Corporation had 52M shares outstanding in Q2 2026. This represents a decrease of 0.2% from the same quarter a year earlier. Against the prior quarter it is down 0.4%.

Margins & Returns

Gross Margin

36.6%

YoY+0.8pp

QoQ+1.5pp

JBT Marel Corporation's gross margin was 36.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Operating Margin

4.7%

YoY-0.4pp

QoQ-2.6pp

JBT Marel Corporation's operating margin was 4.7% in Q2 2026, reflecting core business profitability. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.6 percentage points.

Net Margin

2.9%

YoY+2.5pp

QoQ-2.0pp

5Y change-3.6pp

10Y change-2.9pp

JBT Marel Corporation's net profit margin was 2.9% in Q2 2026, showing the share of revenue converted to profit. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.

Return on Equity

0.6%

YoY+0.6pp

QoQ-0.4pp

5Y change-3.8pp

10Y change-12.0pp

JBT Marel Corporation's ROE was 0.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Capital Allocation

Capital Expenditures

$25.0M

YoY+31.6%

QoQ-3.8%

5Y CAGR+17.0%

10Y CAGR+10.2%

JBT Marel Corporation invested $25.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 31.6% from the same quarter a year earlier. Against the prior quarter it is down 3.8%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

JBTM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JBTM quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.9B	$3.8B+121.3%	$1.7B+3.1%	$1.7B+4.7%	$1.6B-14.9%	$1.9B+8.1%	$1.7B-11.2%	$1.9B+1.4%	$1.9B+17.4%	$1.6B+21.1%	$1.4B+22.0%	$1.1B+12.5%	$984.2M+5.4%	$934.2M+1.8%	$917.3M-4.0%	$955.8M
Cost of Revenue	$2.5B	$2.5B+126.1%	$1.1B+1.0%	$1.1B+1.7%	$1.1B	N/A	N/A	N/A	$1.4B+43.8%	$961.1M+19.6%	$803.8M+18.9%	$676.2M+8.1%	$625.7M+3.2%	$606.4M+2.5%	$591.8M-5.9%	$629.0M
Gross Profit	$1.4B	$1.3B+113.0%	$626.5M+7.0%	$585.7M+129.7%	$255.0M+16.1%	$219.6M-1.7%	$223.5M-15.2%	$263.6M+12.8%	$233.6M+23.1%	$189.8M+19.9%	$158.3M+28.1%	$123.6M+20.4%	$102.7M+12.5%	$91.3M+2.0%	$89.5M+14.3%	$78.3M
R&D Expenses	N/A	$116.3M+456.5%	$20.9M+2.0%	$20.5M-10.9%	$23.0M+4.5%	$22.0M-24.9%	$29.3M+2.8%	$28.5M+5.9%	$26.9M-6.3%	$28.7M+21.6%	$23.6M+29.7%	$18.2M+24.7%	$14.6M+4.3%	$14.0M-2.1%	$14.3M-22.7%	$18.5M
SG&A Expenses	N/A	N/A	N/A	$409.6M+5.1%	$389.7M+10.9%	$351.4M-2.0%	$358.5M-9.6%	$396.4M+14.3%	$346.8M+6.6%	$325.2M+21.6%	$267.4M+29.2%	$207.0M+12.9%	$183.3M+10.0%	$166.6M+6.4%	$156.6M+2.4%	$152.9M
Operating Income	$288.4M	$189.4M+60.0%	$118.4M-28.1%	$164.7M+24.2%	$132.6M+5.6%	$125.6M-23.0%	$163.1M-13.3%	$188.2M+30.9%	$143.8M0.0%	$143.8M+42.4%	$101.0M+13.5%	$89.0M+75.5%	$50.7M-4.7%	$53.2M-12.6%	$60.9M+14.5%	$53.2M
EBITDA	N/A	$455.6M+119.2%	$207.8M-18.8%	$256.0M+19.8%	$213.7M+5.6%	$202.4M-13.8%	$234.9M-7.4%	$253.8M+26.0%	$201.5M+3.1%	$195.5M+40.1%	$139.5M+17.6%	$118.6M+56.1%	$76.0M-2.8%	$78.2M-7.5%	$84.5M+9.3%	$77.3M
Interest Expense	$63.2M	$114.4M+489.7%	$19.4M-20.2%	$24.3M+49.1%	$16.3M+245.5%	-$11.2M-180.6%	$13.9M-26.1%	$18.8M+35.3%	$13.9M+2.2%	$13.6M+44.7%	$9.4M+38.2%	$6.8M-10.5%	$7.6M0.0%	$7.6M+2.7%	$7.4M+5.7%	$7.0M
Income Tax	$46.9M	-$13.1M-222.4%	$10.7M-54.5%	$23.5M+45.1%	$16.2M-40.0%	$27.0M-26.4%	$36.7M-2.4%	$37.6M+52.8%	$24.6M-50.9%	$50.1M+92.7%	$26.0M-0.8%	$26.2M+88.5%	$13.9M+0.7%	$13.8M-18.3%	$16.9M+5.6%	$16.0M
Net Income	$192.5M	-$50.5M-159.1%	$85.4M-85.3%	$582.6M+324.0%	$137.4M+15.4%	$119.1M+9.5%	$108.8M-15.7%	$129.0M+23.9%	$104.1M+29.3%	$80.5M+19.1%	$67.6M+20.9%	$55.9M+81.5%	$30.8M-6.9%	$33.1M-8.6%	$36.2M+18.7%	$30.5M
EPS (Basic)	N/A	-$0.98-136.7%	$2.67-85.3%	$18.21+324.5%	$4.29+15.3%	$3.72+9.4%	$3.40-15.8%	$4.04+23.9%	$3.26+27.3%	$2.56+11.3%	$2.30+21.7%	$1.89+81.7%	$1.04-8.0%	$1.13-8.9%	$1.24+17.0%	$1.06
EPS (Diluted)	$3.68	-$0.98	$2.65-85.4%	$18.13+323.6%	$4.28+15.4%	$3.71+9.4%	$3.39-15.7%	$4.02+24.5%	$3.23+27.7%	$2.53+11.5%	$2.27+20.7%	$1.88+82.5%	$1.03-7.2%	$1.11-9.8%	$1.23+18.3%	$1.04
Diluted Shares (Avg)	N/A	52M	32M+0.3%	32M0.0%	32M0.0%	32M0.0%	32M+0.3%	32M-0.6%	32M+0.9%	32M+7.0%	30M0.0%	30M-0.3%	30M+0.7%	30M+0.7%	30M+0.7%	29M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$981.0M+4.9%	$936.0M+9.6%	$1.0B+124.5%	$1.0B+120.6%	$935.0M+122.1%	$854.0M+117.7%	$448.9M+1.0%	$453.8M0.0%
Cost of Revenue	$622.0M+3.7%	$607.0M+8.0%	$660.1M+129.0%	$641.5M+121.1%	$600.0M+131.6%	$562.0M+123.0%	$288.2M+1.6%	$290.2M+12.1%
Gross Profit	$359.0M+7.2%	$329.0M+12.7%	$347.8M+116.4%	$359.8M+119.9%	$335.0M+106.9%	$292.0M+108.1%	$160.7M-0.1%	$163.6M-16.1%
R&D Expenses	N/A	N/A	$23.1M+600.0%	$28.7M+431.5%	$30.9M+432.8%	$33.6M+425.0%	$3.3M	$5.4M
SG&A Expenses	$313.0M+9.1%	$261.0M-19.7%	N/A	$222.0M+98.9%	$287.0M+160.0%	$325.0M+213.4%	N/A	$111.6M+10.0%
Operating Income	$46.0M-4.2%	$68.0M+306.1%	$72.3M+360.5%	$102.1M+118.2%	$48.0M+79.1%	-$33.0M-213.4%	$15.7M	$46.8M+26.8%
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	$2.0M	$80.0M+33.3%
Interest Expense	$13.0M-59.1%	$10.0M-76.4%	$15.5M+86.7%	$24.7M+502.4%	$31.8M+675.6%	$42.4M+1362.1%	$8.3M	$4.1M-25.5%
Income Tax	$7.0M-12.5%	$15.0M+132.6%	$7.8M+316.7%	$17.1M+80.0%	$8.0M+342.4%	-$46.0M-667.9%	-$3.6M	$9.5M+106.5%
Net Income	$28.0M+833.3%	$45.0M+126.0%	$53.5M+864.3%	$66.0M+69.7%	$3.0M-90.2%	-$173.0M-858.8%	-$7.0M-108.6%	$38.9M-91.2%
EPS (Basic)	$0.54+671.4%	$0.86+125.7%	$1.02+563.6%	$1.26+3.3%	$0.07-92.7%	-$3.35-571.8%	-$0.22-108.7%	$1.22-91.2%
EPS (Diluted)	$0.54+671.4%	$0.86+125.7%	$1.02	$1.26	$0.07-92.6%	-$3.35	-$0.22-108.7%	$1.21-91.2%
Diluted Shares (Avg)	52M0.0%	52M+1.4%	N/A	52M	52M+62.1%	52M	N/A	32M0.0%

JBTM Balance Sheet

JBTM quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$8.2B+139.9%	$3.4B+26.0%	$2.7B+2.6%	$2.6B+20.9%	$2.2B+21.0%	$1.8B-5.7%	$1.9B+32.7%	$1.4B+3.7%	$1.4B+17.2%	$1.2B+35.5%	$876.1M+25.6%	$697.8M+12.3%	$621.2M-8.4%	$678.0M+14.5%	$592.2M
Current Assets	$1.6B-15.0%	$1.9B+69.4%	$1.1B+18.7%	$926.5M+21.5%	$762.5M+23.8%	$616.1M-13.0%	$708.2M+14.5%	$618.5M+5.1%	$588.6M+21.4%	$485.0M+22.4%	$396.2M+8.6%	$364.7M-8.0%	$396.6M-12.1%	$451.1M+21.6%	$370.9M
Cash & Equivalents	$167.9M-86.3%	$1.2B+154.2%	$483.3M+574.1%	$71.7M-6.8%	$76.9M+61.9%	$47.5M+20.3%	$39.5M-8.1%	$43.0M+26.5%	$34.0M+2.4%	$33.2M-10.8%	$37.2M+11.7%	$33.3M+13.3%	$29.4M-70.3%	$99.0M+1000.0%	$9.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$644.0M+176.3%	$233.1M-2.4%	$238.9M-9.5%	$264.0M+43.6%	$183.8M-6.8%	$197.3M-19.5%	$245.0M+18.9%	$206.1M+8.4%	$190.2M+36.2%	$139.6M+33.1%	$104.9M-6.2%	$111.8M-4.9%	$117.6M+7.7%	$109.2M-10.7%	$122.3M
Accounts Receivable	$443.0M+84.8%	$239.7M+11.8%	$214.4M+6.9%	$200.5M+21.4%	$165.2M-30.0%	$236.1M-18.3%	$288.9M+14.0%	$253.4M+12.2%	$225.8M-13.3%	$260.5M+22.6%	$212.5M+20.6%	$176.2M-5.5%	$186.4M-1.1%	$188.4M-0.5%	$189.4M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.4B+345.7%	$769.1M-1.3%	$779.5M+1.2%	$770.1M+19.1%	$646.7M+27.9%	$505.7M-4.4%	$528.9M+64.6%	$321.4M+6.5%	$301.8M+26.0%	$239.5M+57.0%	$152.5M+120.4%	$69.2M+124.7%	$30.8M+0.7%	$30.6M+8.5%	$28.2M
Total Liabilities	$3.7B+99.3%	$1.9B+53.1%	$1.2B-29.6%	$1.7B+24.1%	$1.4B+23.4%	$1.1B-15.7%	$1.3B+36.5%	$985.6M+3.8%	$949.5M-5.8%	$1.0B+35.0%	$746.4M+29.0%	$578.6M+24.0%	$466.8M-18.4%	$572.4M+11.7%	$512.4M
Current Liabilities	$1.6B+202.9%	$535.5M+10.5%	$484.4M-22.4%	$624.0M+13.9%	$547.7M+19.7%	$457.5M-3.6%	$474.5M-2.2%	$485.3M+9.9%	$441.4M+12.3%	$393.0M+11.3%	$353.1M+25.1%	$282.3M+1.7%	$277.6M+10.7%	$250.8M+4.6%	$239.7M
Non-Current Liabilities	$2.1B+57.8%	$1.3B+81.0%	$737.1M-33.7%	$1.1B+30.6%	$850.9M+25.9%	$676.0M-22.4%	$870.9M+74.1%	$500.3M-1.5%	$508.1M-17.3%	$614.5M+56.2%	$393.3M+32.7%	$296.3M+56.6%	$189.2M-41.2%	$321.6M+17.9%	$272.7M
Long-Term Debt	$1.5B+17.4%	$1.3B+93.7%	$646.4M-33.9%	$977.3M+44.9%	$674.4M+29.1%	$522.5M-25.2%	$698.3M+80.4%	$387.1M+3.9%	$372.7M-24.2%	$491.6M+75.2%	$280.6M+61.4%	$173.8M+84.7%	$94.1M-50.2%	$189.1M+39.4%	$135.7M
Total Equity	$4.5B+189.1%	$1.5B+3.7%	$1.5B+64.4%	$905.4M+15.1%	$786.5M+17.0%	$672.4M+18.1%	$569.5M+24.6%	$456.9M+3.4%	$441.9M+145.6%	$179.9M+38.7%	$129.7M+8.8%	$119.2M-22.8%	$154.4M+46.2%	$105.6M+32.3%	$79.8M
Retained Earnings	$1.5B-4.6%	$1.5B+4.9%	$1.5B+63.7%	$894.0M+16.2%	$769.4M+22.6%	$627.8M+17.8%	$532.8M+27.9%	$416.5M+24.8%	$333.7M+25.2%	$266.6M+26.3%	$211.1M+26.9%	$166.4M+13.6%	$146.5M+18.6%	$123.5M+28.9%	$95.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$8.0B-3.0%	$8.2B+2.0%	$8.2B+139.9%	$8.2B+194.0%	$8.3B+206.8%	$8.0B+197.3%	$3.4B+26.0%	$2.8B+3.7%
Current Assets	$1.6B+5.6%	$1.7B+12.5%	$1.6B-15.0%	$1.5B+27.7%	$1.5B+35.9%	$1.5B+35.0%	$1.9B+69.4%	$1.2B+10.4%
Cash & Equivalents	$112.0M-13.8%	$230.0M+93.3%	$167.9M-86.3%	$133.3M-75.1%	$130.0M-72.6%	$119.0M-75.2%	$1.2B+154.2%	$534.5M+33.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0-100.0%
Inventory	$700.0M+5.9%	$667.0M+8.7%	$644.0M+176.3%	$669.4M+158.5%	$661.1M+155.5%	$613.5M+145.2%	$233.1M-2.4%	$259.0M+14.2%
Accounts Receivable	$443.0M+7.1%	$438.0M+9.7%	$443.0M+84.8%	$434.6M+82.7%	$413.7M+81.1%	$399.3M+80.9%	$239.7M+11.8%	$237.9M+24.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.4B+9.1%	$3.4B+19.7%	$3.4B+345.7%	$3.4B+335.1%	$3.1B+300.6%	$2.8B+265.6%	$769.1M-1.3%	$785.8M+2.0%
Total Liabilities	$3.5B-8.9%	$3.7B-5.5%	$3.7B+99.3%	$3.8B+213.9%	$3.9B+231.1%	$3.9B+224.5%	$1.9B+53.1%	$1.2B-7.1%
Current Liabilities	$1.3B-20.7%	$1.7B+40.0%	$1.6B+202.9%	$1.6B+248.4%	$1.6B+271.1%	$1.2B+153.9%	$535.5M+10.5%	$473.4M-19.0%
Non-Current Liabilities	$2.2B-0.2%	$2.0B-25.3%	$2.1B+57.8%	$2.1B+191.5%	$2.2B+206.8%	$2.7B+269.3%	$1.3B+81.0%	$730.5M+2.7%
Long-Term Debt	$1.7B+10.5%	$1.4B-27.2%	$1.5B+17.4%	$1.5B+130.6%	$1.5B+133.4%	$2.0B+203.9%	$1.3B+93.7%	$648.3M+0.4%
Total Equity	$4.5B+2.2%	$4.5B+9.2%	$4.5B+189.1%	$4.4B+178.9%	$4.4B+188.0%	$4.1B+175.4%	$1.5B+3.7%	$1.6B+13.8%
Retained Earnings	$1.5B+12.6%	$1.5B+10.8%	$1.5B-4.6%	$1.4B-8.4%	$1.4B-10.2%	$1.4B-8.4%	$1.5B+4.9%	$1.5B+13.2%

JBTM Cash Flow Statement

JBTM quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$425.7M	$341.7M+46.9%	$232.6M+213.5%	$74.2M-47.9%	$142.3M-37.0%	$225.7M-10.4%	$252.0M+128.7%	$110.2M-28.4%	$153.9M+47.1%	$104.6M+55.2%	$67.4M-39.8%	$111.9M+44.0%	$77.7M+25.3%	$62.0M-27.9%	$86.0M+136.3%	$36.4M
Depreciation & Amortization	N/A	$266.2M+197.8%	$89.4M-2.1%	$91.3M+12.6%	$81.1M+5.6%	$76.8M+7.0%	$71.8M+9.5%	$65.6M+13.7%	$57.7M+11.6%	$51.7M+34.3%	$38.5M+30.1%	$29.6M+17.0%	$25.3M+1.2%	$25.0M+5.9%	$23.6M-2.1%	$24.1M
Stock-Based Compensation	N/A	$23.2M+57.8%	$14.7M+28.9%	$11.4M+28.1%	$8.9M+61.8%	$5.5M+189.5%	$1.9M-79.8%	$9.4M-3.1%	$9.7M+7.8%	$9.0M-9.1%	$9.9M+37.5%	$7.2M-1.4%	$7.3M+5.8%	$6.9M-8.0%	$7.5M+44.2%	$5.2M
Capital Expenditures	$115.6M	$103.6M+173.4%	$37.9M-31.2%	$55.1M-34.9%	$84.6M+63.6%	$51.7M+50.7%	$34.3M-9.5%	$37.9M-4.8%	$39.8M+5.0%	$37.9M+2.2%	$37.1M-1.6%	$37.7M+2.7%	$36.7M+25.7%	$29.2M+18.2%	$24.7M+18.8%	$20.8M
Free Cash Flow	$310.1M	$238.1M+22.3%	$194.7M+919.4%	$19.1M-66.9%	$57.7M-66.8%	$174.0M-20.1%	$217.7M+201.1%	$72.3M-36.6%	$114.1M+71.1%	$66.7M+120.1%	$30.3M-59.2%	$74.2M+81.0%	$41.0M+25.0%	$32.8M-46.5%	$61.3M+292.9%	$15.6M
Investing Cash Flow	N/A	N/A	N/A	N/A	-$416.1M-52.5%	-$272.9M-631.6%	-$37.3M+90.7%	-$401.7M-325.5%	-$94.4M+32.5%	-$139.9M+47.6%	-$266.8M-44.1%	-$185.1M-46.2%	-$126.6M-350.5%	-$28.1M+13.8%	-$32.6M-52.3%	-$21.4M
Financing Cash Flow	-$338.9M	$458.1M-18.5%	$561.8M+258.7%	-$354.1M-230.9%	$270.6M+234.9%	$80.8M+139.0%	-$207.4M-172.1%	$287.5M+695.2%	-$48.3M-239.2%	$34.7M-82.2%	$194.9M+132.3%	$83.9M+35.5%	$61.9M+160.9%	-$101.6M-381.4%	$36.1M+295.1%	-$18.5M
Dividends Paid	$20.9M	$20.9M+59.5%	$13.1M+2.3%	$12.8M-2.3%	$13.1M+2.3%	$12.8M0.0%	$12.8M+0.8%	$12.7M-3.1%	$13.1M+3.1%	$12.7M+7.6%	$11.8M+5.4%	$11.2M+4.7%	$10.7M+5.9%	$10.1M+18.8%	$8.5M+1.2%	$8.4M
Share Buybacks	N/A	$0	$0-100.0%	$5.1M-33.8%	$7.7M	$0	$0	$0-100.0%	$20.0M+300.0%	$5.0M+16.3%	$4.3M-44.2%	$7.7M+175.0%	$2.8M+1300.0%	$200K-94.4%	$3.6M+1100.0%	$300K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$102.0M-1.0%	$119.0M+250.0%	$117.4M-8.8%	$87.3M+21.4%	$103.0M+376.9%	$34.0M+226.9%	$128.7M+701.4%	$71.9M+117.9%
Depreciation & Amortization	N/A	N/A	N/A	N/A	N/A	N/A	-$13.7M	$33.2M+43.7%
Stock-Based Compensation	N/A	$7.0M+40.0%	N/A	N/A	N/A	$5.0M+19.0%	N/A	N/A
Capital Expenditures	$25.0M+31.6%	$26.0M+30.0%	$33.9M+239.0%	$30.7M+344.9%	$19.0M+81.0%	$20.0M+90.5%	$10.0M+12.4%	$6.9M-36.7%
Free Cash Flow	$77.0M-8.3%	$93.0M+564.3%	$83.5M-29.7%	$56.6M-12.9%	$84.0M+656.8%	$14.0M+14100.0%	$118.7M+491.7%	$65.0M+194.1%
Investing Cash Flow	-$23.0M-64.3%	-$19.0M+98.9%	N/A	-$31.3M-244.0%	-$14.0M+9.7%	-$1.8B-24427.8%	N/A	-$9.1M
Financing Cash Flow	-$200.0M-156.4%	-$54.0M-108.7%	-$32.8M-105.6%	-$52.1M-677.6%	-$78.0M-657.3%	$621.0M+10280.3%	$584.9M+7063.1%	-$6.7M+97.8%
Dividends Paid	$6.0M0.0%	$5.0M0.0%	$5.2M+48.6%	$4.7M+46.9%	$6.0M+87.5%	$5.0M+56.3%	$3.5M+12.9%	$3.2M-3.0%

Not reported in any period shown, so not listed: Share Buybacks.

JBTM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JBTM quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	35.1%-1.4pp	36.5%+1.3pp	35.2%+19.2pp	16.0%+4.3pp	11.8%-1.2pp	12.9%-0.6pp	13.6%+1.4pp	12.2%+0.6pp	11.6%-0.1pp	11.7%+0.6pp	11.2%+0.7pp	10.4%+0.7pp	9.8%0.0pp	9.8%+1.6pp	8.2%
Operating Margin	5.0%-1.9pp	6.9%-3.0pp	9.9%+1.6pp	8.3%+1.6pp	6.7%-2.7pp	9.4%-0.2pp	9.7%+2.2pp	7.5%-1.3pp	8.8%+1.3pp	7.5%-0.6pp	8.0%+2.9pp	5.1%-0.5pp	5.7%-1.0pp	6.6%+1.1pp	5.6%
Net Margin	-1.3%-6.3pp	5.0%-30.0pp	35.0%+26.4pp	8.6%+2.3pp	6.4%+0.1pp	6.3%-0.3pp	6.6%+1.2pp	5.4%+0.5pp	4.9%-0.1pp	5.0%0.0pp	5.1%+1.9pp	3.1%-0.4pp	3.5%-0.4pp	4.0%+0.8pp	3.2%
Return on Equity	-1.1%-6.7pp	5.5%-33.6pp	39.1%+23.9pp	15.2%0.0pp	15.1%-1.0pp	16.2%-6.5pp	22.7%-0.1pp	22.8%+4.6pp	18.2%-19.4pp	37.6%-5.5pp	43.1%+17.3pp	25.8%+4.4pp	21.4%-12.8pp	34.3%-3.9pp	38.2%
Return on Assets	-0.6%-3.1pp	2.5%-19.0pp	21.5%+16.3pp	5.2%-0.3pp	5.5%-0.6pp	6.0%-0.7pp	6.7%-0.5pp	7.2%+1.4pp	5.8%+0.1pp	5.7%-0.7pp	6.4%+2.0pp	4.4%-0.9pp	5.3%0.0pp	5.3%+0.2pp	5.1%
Current Ratio	0.98-2.5x	3.48+1.2x	2.27+0.8x	1.48+0.1x	1.390.0x	1.35-0.1x	1.49+0.2x	1.27-0.1x	1.33+0.1x	1.23+0.1x	1.12-0.2x	1.29-0.1x	1.43-0.4x	1.80+0.3x	1.55
Debt-to-Equity	0.33-0.5x	0.81+0.4x	0.43-0.6x	1.08+0.2x	0.86+0.1x	0.78-0.4x	1.23+0.4x	0.850.0x	0.84-1.9x	2.73+0.6x	2.16+0.7x	1.46+0.8x	0.61-1.2x	1.79+0.1x	1.70
Asset Turnover	0.460.0x	0.50-0.1x	0.610.0x	0.60-0.3x	0.85-0.1x	0.96-0.1x	1.02-0.3x	1.33+0.2x	1.180.0x	1.14-0.1x	1.26-0.1x	1.41-0.1x	1.50+0.2x	1.35-0.3x	1.61
FCF Margin	6.3%-5.1pp	11.3%+10.2pp	1.1%-2.5pp	3.6%-5.7pp	9.3%-3.3pp	12.6%+8.9pp	3.7%-2.2pp	5.9%+1.9pp	4.1%+1.8pp	2.2%-4.5pp	6.7%+2.5pp	4.2%+0.7pp	3.5%-3.2pp	6.7%+5.1pp	1.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	36.6%+0.8pp	35.1%+1.0pp	34.5%-1.3pp	35.9%-0.1pp	35.8%-2.6pp	34.2%-1.6pp	35.8%-0.4pp	36.0%-6.9pp
Operating Margin	4.7%-0.4pp	7.3%+11.1pp	7.2%+3.7pp	10.2%-0.1pp	5.1%-1.2pp	-3.9%-11.3pp	3.5%	10.3%+2.2pp
Net Margin	2.9%+2.5pp	4.8%+25.1pp	5.3%+6.9pp	6.6%-2.0pp	0.3%-7.0pp	-20.3%-26.1pp	-1.6%-19.8pp	8.6%-88.7pp
Return on Equity	0.6%+0.6pp	1.0%+5.2pp	1.2%+1.7pp	1.5%-1.0pp	0.1%-1.9pp	-4.2%-5.7pp	-0.5%-5.9pp	2.5%-29.3pp
Return on Assets	0.4%+0.3pp	0.5%+2.7pp	0.7%+0.9pp	0.8%-0.6pp	0.0%-1.1pp	-2.2%-3.0pp	-0.2%-3.2pp	1.4%-15.0pp
Current Ratio	1.24+0.3x	1.01-0.2x	0.98-2.5x	0.93-1.6x	0.93-1.6x	1.26-1.1x	3.48+1.2x	2.55+0.7x
Debt-to-Equity	0.370.0x	0.32-0.2x	0.33-0.5x	0.34-0.1x	0.35-0.1x	0.480.0x	0.81+0.4x	0.41-0.1x
Asset Turnover	0.120.0x	0.110.0x	0.120.0x	0.120.0x	0.110.0x	0.110.0x	0.130.0x	0.160.0x
FCF Margin	7.8%-1.1pp	9.9%+8.3pp	8.3%-18.2pp	5.7%-8.7pp	9.0%+6.3pp	1.6%+1.7pp	26.4%+33.3pp	14.3%+9.4pp

Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
JBT Marel Corporation JBTM	FY2025	$3.8B	-$50.5M	-1.3%	$5.9B	51/100
Flowserve Corporation FLS	FY2025	$4.7B	$346.2M	7.3%	$9.3B	57/100
Middleby Corp MIDD	FY2025	$3.2B	$367.3M	11.5%	$4.8B	62/100
Chart Industries, Inc. GTLS	FY2025	$4.3B	$40.7M	0.9%	$10.0B	54/100
Donaldson Company, Inc. DCI	FY2025	$3.7B	$367.0M	9.9%	$10.2B	66/100
Watts Water Technologies, Inc. WTS	FY2025	$2.4B	$340.8M	14.0%	$11.7B	80/100

Where JBT Marel Corporation Ranks

Frequently Asked Questions

What is JBT Marel Corporation's annual revenue?

JBT Marel Corporation (JBTM) reported $3.8B in total revenue for fiscal year 2025. This represents a 121.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is JBT Marel Corporation's revenue growing?

JBT Marel Corporation (JBTM) revenue grew by 121.3% year-over-year, from $1.7B to $3.8B in fiscal year 2025.

Is JBT Marel Corporation profitable?

No, JBT Marel Corporation (JBTM) reported a net income of -$50.5M in fiscal year 2025, with a net profit margin of -1.3%.

What is JBT Marel Corporation's EBITDA?

JBT Marel Corporation (JBTM) had EBITDA of $455.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does JBT Marel Corporation have?

As of fiscal year 2025, JBT Marel Corporation (JBTM) had $167.9M in cash and equivalents against $1.5B in long-term debt.

What is JBT Marel Corporation's gross margin?

JBT Marel Corporation (JBTM) had a gross margin of 35.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is JBT Marel Corporation's operating margin?

JBT Marel Corporation (JBTM) had an operating margin of 5.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is JBT Marel Corporation's net profit margin?

JBT Marel Corporation (JBTM) had a net profit margin of -1.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does JBT Marel Corporation pay dividends?

Yes, JBT Marel Corporation (JBTM) paid $0.40 per share in dividends during fiscal year 2025.

What is JBT Marel Corporation's return on equity (ROE)?

JBT Marel Corporation (JBTM) has a return on equity of -1.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is JBT Marel Corporation's free cash flow?

JBT Marel Corporation (JBTM) generated $238.1M in free cash flow during fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is JBT Marel Corporation's operating cash flow?

JBT Marel Corporation (JBTM) generated $341.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are JBT Marel Corporation's total assets?

JBT Marel Corporation (JBTM) had $8.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are JBT Marel Corporation's capital expenditures?

JBT Marel Corporation (JBTM) invested $103.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does JBT Marel Corporation spend on research and development?

JBT Marel Corporation (JBTM) invested $116.3M in research and development during fiscal year 2025.

How many shares does JBT Marel Corporation have outstanding?

JBT Marel Corporation (JBTM) had 52M shares outstanding as of fiscal year 2025.

What is JBT Marel Corporation's current ratio?

JBT Marel Corporation (JBTM) had a current ratio of 0.98 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is JBT Marel Corporation's debt-to-equity ratio?

JBT Marel Corporation (JBTM) had a debt-to-equity ratio of 0.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is JBT Marel Corporation's return on assets (ROA)?

JBT Marel Corporation (JBTM) had a return on assets of -0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is JBT Marel Corporation's P/E ratio?

JBT Marel Corporation (JBTM) trades at 30.8x earnings, its market capitalization divided by net income of $192.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $5.9B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is JBT Marel Corporation's price-to-sales ratio?

JBT Marel Corporation (JBTM) trades at 1.5x sales, its market capitalization divided by revenue of $3.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $5.9B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is JBT Marel Corporation's Altman Z-Score?

JBT Marel Corporation (JBTM) has an Altman Z-Score of 1.74, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is JBT Marel Corporation's Piotroski F-Score?

JBT Marel Corporation (JBTM) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are JBT Marel Corporation's earnings high quality?

JBT Marel Corporation (JBTM) reported a net loss of $50.5M while generating $341.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can JBT Marel Corporation cover its interest payments?

JBT Marel Corporation (JBTM) has an interest coverage ratio of 1.66x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is JBT Marel Corporation?

JBT Marel Corporation (JBTM) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.